HJ SCIENCE-B

6132
29.6008.75% ( -2.840 )
Delay Closed: Nov 16, 16:08:11

Overview

HJ SCIENCE-B (6132)

HJ Science Co., Ltd. engages in research and development of new small molecule drugs in the People’s Republic of China. It focuses on autoimmune, metabolic dise...

Open
32.180
High
32.180
Low
28.420
Prev. Close
32.440
Volume
109.20K
Turnover
3.24M
Avg Price
29.641
Bid/Ask Ratio
-60.00%
Amplitude
11.59%
52wk High
82.000
Volume Ratio
0.61
Turnover Ratio
0.16%
52wk Low
25.880
HK Mkt Cap
1.99B
Market CapHKD
2.18B
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-2.44
EPSDynamic
-2.30
EPSStatic
--
BVPS
18.92
P/B
1.56
HK Shares
67.33M
Dividend YieldTTM
--
DividendTTM
--
Shares
73.56M
Min lot size
100
Currency
HKD

Daily Events

  1. Nov, 16

    HJ Science-B (6132.HK) spiked and faded, opening at HK$32.18, tagging an intraday high of HK$32.44 at the open before sliding to HK$28.48 in the afternoon and closing at HK$29.60, down about 8.8% from the prior close of HK$32.44, in line with reports of a 12% tumble; turnover was thin at 103,700 shares worth roughly HK$3.07 million, a 0.16% turnover rate. A buyback of up to HK$100 million of H shares plus repeated next-day disclosure returns had lifted the stock 5.97% in a week, but that support did not hold. Q2 2026 revenue rose 119.14% year on year to HK$1.17 million while net loss widened 46.28% to HK$42.43 million, leaving revenue far short of spending. The shares sit 63.9% below the HK$82 52-week high and 14.37% above the HK$25.88 low, under both MA20 of HK$31.36 and MA60 of HK$37.51, down 16.05% year to date. Though at 1.56x PB and HK$2.18 billion market cap, buyback execution remains the variable to watch.

  2. Nov, 13

    HJ Science (6132.HK) reversed an early advance to close down 3.0% at HK$32.44, having touched HK$34.50 by 09:59 BJ before sliding to a HK$31.68 low at 15:59, on just 79,100 shares and HK$2.62 million turnover (0.12% turnover rate), as the HK$100 million H-share buyback and repeated next-day disclosure filings that fuelled last week's roughly 6% rebound failed to carry into today. Revenue and losses expanded together: Q2 2026 revenue of HK$1.1706 million rose 119.14% year on year, while net loss widened 46.28% to HK$42.43 million and loss per share reached HK$0.7002. The quote remains 60.44% below its 52-week high of HK$82 and is down 8% year to date, 25.35% above the 29 October low of HK$25.88, sitting just above the MA20 of HK$31.60 yet well under the MA60 of HK$37.66. Though the session range reached 8.4%, volume below 80,000 shares leaves pricing highly sensitive to isolated trades.

  3. Nov, 12

    HJ Science (6132.HK) reversed early weakness to close at HK$33.44, up 0.9% from the prior HK$33.14, as the up-to-HK$100 million H-share buyback plan kept driving flow, with the company filing successive next-day disclosure returns on repurchases. The stock opened at 33.14, slipped to 32.28 in the morning session and 32.12 at 13:53 BJ, then rebounded to 34.68 by 15:44 BJ before fading; turnover reached HK$2.69 million with a thin 0.12% turnover rate. Fundamentals contrast with the tape: Q2 2026 revenue of HK$1.17 million rose 119.14% year on year, yet the net loss widened 46.28% to HK$42.43 million, with EPS of -HK$0.7002, ROE -12.16% and PB 1.77x. The price sits 59.22% below its 52-week high of HK$82 and down 5.16% year to date, above MA20 of 31.75 but below MA60 of 37.76. Though the absolute revenue base remains small, the tension between widening losses and buyback support is yet to be resolved.

  4. Nov, 6

    HJ Science (6132.HK) reversed early strength to close at HK$31.96, down 3.27%, with the HK$33.04 open marking the session high and the afternoon sliding to HK$31.02 at 15:08, partly unwinding a three-day advance of 13% to nearly 20% that followed a plan to repurchase up to HK$100 million of H shares. Fundamentals cut against the tape: Q2 2026 revenue of HK$1.17 million rose 119% year on year, yet the net loss widened 46% to HK$42.4 million, EPS came in at -HK$0.70, net margin at -3,625%, alongside a -13.1x PE, 1.69x PB and HK$2.35 billion market value. The price position stays weak, down 9.36% year to date, 61% below the June 22 52-week high of HK$82 and 23.5% above the October 29 low of HK$25.88, trading under both MA20 at HK$32.08 and MA60 at HK$38.29. Though execution of the buyback has yet to be disclosed, follow-up filings may keep short-term trading choppy.

  5. Nov, 5

    HJ Science-B spiked in the morning and faded in the afternoon: it probed HK$34.08 (up about 5.5%) at 09:41, slipped to HK$32.50 in the afternoon session and closed at HK$33.04, up 2.3%, on HK$3.33 million turnover, as the plan to repurchase up to HK$100 million of H shares extended a multi-session rebound while buying thinned out. Fundamentals cut against the tape: Q2 2026 revenue rose 119% year on year to HK$1.17 million, yet the net loss widened 46% to HK$42.43 million and the per-share loss deepened 41% to HK$0.7002, leaving PE at -13.57 against PB 1.75 and a HK$2.43 billion market cap. The stock still trades below its MA60 of HK$38.46 and sits 59.71% under the June 22 52-week high of HK$82, down 6.3% year to date, though it holds above the MA20 of HK$32.35 and is 27.67% above the October 29 low of HK$25.88. Though a HK$100 million buyback against a HK$2.43 billion cap and 0.15% turnover leaves the actual support unproven.

News